Irreversible Telomere Shortening by 3′-Azido-2′, 3′-Dideoxythymidine (AZT) Treatment
Authors:
- Daniel E. GomezDGDaniel E. Gomez
- Agueda M. TejeraATAgueda M. Tejera
- Ofelia A. OliveroOOOfelia A. Olivero
- 1 May 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 246 (1) , 107-110
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Telomeres and Senescence: Ending the DebateScience, 1998
- Extension of Life-Span by Introduction of Telomerase into Normal Human CellsScience, 1998
- Transplacental Effects of 3'-Azido-2',3'-Dideoxythymidine (AZT): Tumorigenicity in Mice and Genotoxicity in Mice and MonkeysJNCI: Journal of the National Cancer Institute, 1997
- Reverse transcriptase inhibitors suppress telomerase function and induce senescence‐like processes in cultured mouse fibroblastsFEBS Letters, 1996
- Effects of Reverse Transcriptase Inhibitors on Telomere Length and Telomerase Activity in Two Immortalized Human Cell LinesMolecular and Cellular Biology, 1996
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- The effects of nucleoside analogs on telomerase and telomeres inTetrahymenaNucleic Acids Research, 1994
- Telomere length predicts replicative capacity of human fibroblasts.Proceedings of the National Academy of Sciences, 1992
- Telomere end-replication problem and cell agingJournal of Molecular Biology, 1992
- Telomeres shorten during ageing of human fibroblastsNature, 1990